Factor VII deficiency
PDF (Spanish)

Keywords

Congenital coagulation disorder
factor VII deficiency
diagnosis and management factor VII deficiency
factor VII concentrates
recombinant factor VIIa
haemophilia
thrombosis
haemostasis
vitamin K-dependent factors

How to Cite

Factor VII deficiency. (2009). Universitas Medica, 51(1), 86-93. https://doi.org/10.11144/Javeriana.umed51-1.dfvr
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar

Abstract

Factor VII deficiency is a rare hemorrhagic disease caused by the decrease or absence of this coagulation factor; no more than 200 cases have been reported since it was first discovered in 1951.


It is an autosomal recessive disorder, which may affect several members of a family. Its prevalence is 1:500,000 (0.5% of all hereditary disorders of
coagulation) and its distribution is the same in both genders.

The defect is located on chromosome 13q34. Only homozygous or compound heterozygous individuals have different hemorrhagic manifestations.

The heterozygotes are asymptomatic.

The deficit may be qualitative or quantitative.

The clinical manifestations are variable and the severity of bleeding is not directly related to factor VII titers or its activity.


The clinical picture may be very severe, patients could present with an early intracerebral hemorrhage, hemarthrosis or moderate findings, given by mucocutaneous bleeding or bleeding after surgery, moreover in some cases it may be asymptomatic despite very low values of factor VII.


The diagnosis is made by coagulation tests to find a prolonged prothrombin time with a normal PTT and the subsequent quantification of factor VII
decreased (VN 70-130%).

PDF (Spanish)

Blackwell Science Ltd. Factor VII deficiency. Br J Hematol. 2002;118:689-700. Este es un grupo editorial y el nombre del grupo editorial es uno de los autores principales BLACWELL. También aparece así en internet.

Boltin D, Boguslavski V, Goor Y, Elkayam O. Primary Factor VII deficiency. IMAJ. 2008;10:475-6.

Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia. 2002;8:308-21.

Brooks BP, Meck JM, Haddad BR, Bendavid C, Blain D, Toretsky JA. Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature. BMC Medical Genetics. 2006;7:2.

Giansily-Blazot M. Inherited factor VII deficiency. Orphanet Encyclopedia, junio 2004.

Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood. 2004;104:1243-52.

Dike GW, Griffths D, Bidwell E, Snape TJ, Rizza CR. A factor VII concentrate for therapeutic use. Br J Hematol. 1980;45:107-18.

Ingerslev J, Knudsen L, Hvid L, Tnage MR, Fedberg U, Sneppen O. Use of recombinant factor VIIa in surgery in factor VII deficient patients. Haemophilia. 1997;3:215-8.

Jiménez-Yuste V, Villar A, Morado M, Canales M, Hernández MC, Sanjurjo MJ, et al. Continuos infusión of recombinant activated factor VII during cesarean section delivery in patient with congenital factor VII deficiency. Haemophilia. 2000;6:588-90.

This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.

Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.